Manufacturer: Crowx Labs
Pharmaceutical name: Human Chorionic Gonadotropin
Pack: 1 vial (5000iu)
HCG is a hormone that is naturally generated by the female placenta during a normal pregnancy. The action of this medication closely resembles that of luteinizing hormone (LH), which is known to trigger ovulation. When used alongside other medications and drugs, HCG is particularly effective in assisting female patients in achieving pregnancy. This medication can also be beneficial for male patients experiencing fertility issues, often leading to increased levels of testosterone.
HCG is a commonly prescribed medication for female patients as part of a treatment plan aimed at: Inducing ovulation in cases of subfertility typically caused by impaired follicle maturation or anovulation. - Providing luteal phase support. Preparing follicles for extraction in controlled ovarian hyperstimulation programs (often utilized in medically assisted reproductive techniques).
HCG is frequently prescribed for male patients due to its efficacy in treating Hypogonadotrophic hypogonadism. Some individuals with idiopathic dysspermia have shown positive responses to treatment with this medication. It is also used for delayed puberty associated with insufficient function of the gonadotrophic pituitary glands and for cryptorchidism (not caused by an anatomical obstruction).
This popular medicine assists both male and female patients in addressing infertility. Nonetheless, it is also applicable for various other medical conditions that are not detailed here.
For female patients considering treatment with HCG: Infertile women undergoing medically assisted reproduction (especially those requiring in vitro fertilization) often have tubal abnormalities, which can lead to a higher incidence of ectopic pregnancies after treatment with this drug. Thus, early ultrasound validation at the start of a pregnancy (to determine if the pregnancy is intrauterine) is essential. Pregnancies resulting from this treatment carry an increased risk of multiples. Female patients with thrombosis, severe obesity, or thrombophilia should not receive this medication, as they face a greater risk of arterial or venous thromboembolic events during or post-treatment with HCG. Additionally, women treated with this medication tend to have a higher likelihood of pregnancy loss.